Project Grant K23DA063936
Award Date 9/1/25
Completion Date 8/31/30
Dollars Obligated $196K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
- This $181,681 federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the NIH Drug Use and Addiction Research Programs (CFDA 93.279), aims to integrate a harm reduction-focused behavioral intervention into the Formerly Incarcerated Transition (FIT) primary care program. The grant will fund a three-part research study to: 1) Identify barriers and facilitators to implementing the harm reduction therapy in a primary care setting through qualitative interviews; 2)...
- This $352,540 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to improve understanding of effective anticipatory guidance techniques and design an intervention to prevent postoperative opioid misuse (POM) among adolescent surgical patients. The principal investigator, Dr. Sutherland at the Children's Hospital of Philadelphia (CHOP), will conduct a retrospective cohort study to establish...
- This federal Project Grant award of $770,461.00 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant, titled "Police Pathways to Addiction Treatment, Health, and Safety: The Police PATHS Study", aims to investigate implementation gaps in police-assisted diversion (PAD) programs that link people who use drugs (PWUD) to treatment and services, especially medications for opioid use disorder. The project...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $753,286 to develop and pilot an integrated HIV/overdose education and naloxone distribution (OEND) peer navigation intervention targeting Latinx people who use and sell drugs (PWUSD) in Kensington, Philadelphia. The 3-year study aims to train 45 PWUSD in naloxone use and distribution, and link them to pre-exposure prophylaxis (PrEP) services through...
- This $189,500.00 Project Grant award was provided by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to determine the extent to which cardiovascular disease (CVD) affects people with opioid use disorder (OUD) and identify ways to prevent CVD in this population. To achieve this, the project will: 1) Examine the relationship between CVD and OUD using Transformed...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $216,724 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Dr. Meghan D. Morris at the University of California, San Francisco (UCSF). The grant, effective July 15, 2025 through June 30, 2030, will support Dr. Morris's research program focused on addressing health inequities among people who inject drugs (PWID). Specifically, the funding will enable Dr. Morris...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports a 5-year, $187,164 research project at Temple University to study the impact of Medicaid "Institutions for Mental Diseases" (IMD) waivers on the utilization of medications for opioid use disorder (MOUD) treatment. The key objectives are to: 1) characterize IMD waiver features across jurisdictions to enable comparison, 2) measure the...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $187,023 to Baystate Medical Center, Inc. in Massachusetts. The purpose is to conduct a mixed-methods study to determine the impact of the state's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program on healthcare utilization, costs, and overdose outcomes for individuals with opioid use disorder (OUD) upon release from...
- This federal Project Grant award, titled "Integrated Services for PWID Using Person-Centered Interactions, Reach, and Engagement (INSPIRE)", is funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The University of Maryland, Baltimore was awarded $219,291 on September 30, 2025 to co-adapt and evaluate an HIV status-neutral collaborative care management model for HIV prevention, HIV care, mental health, and medication...
- This $194,098 Project Grant award under the National Institute on Drug Abuse's (NIDA) Drug Use and Addiction Research Programs (CFDA 93.279) is designed to provide the principal investigator, Dr. Erath, with mentored training in implementation science to become an independent investigator focused on advancing the implementation of evidence-based treatments for stimulant use disorder and other substance use disorders in harm reduction and community treatment settings. The key objectives of the...